Does Bacterial Contamination Affect Implant Success?

Introduction

Dental implants have revolutionized how we restore missing teeth. Thanks to advancements in surgical techniques and implant materials, modern implant dentistry has become a predictable and effective treatment option. However, as with any surgical procedure, implants are not immune to complications. One potential risk factor under investigation is bacterial contamination during surgery.

Orthopedic surgeons have long acknowledged the relationship between surgical contamination and implant failure. But can the same be said for dental implants placed in the oral cavity—a naturally bacteria-rich environment? This article reviews current preclinical studies to examine whether bacterial contamination at the time of implant placement may affect osseointegration and long-term implant success.

Understanding the Risk of Contamination

Dental implants are placed in a space populated by hundreds of bacterial species. Even in a surgically sterile setting, factors such as saliva exposure and airborne contamination may introduce bacteria to the implant surface. Once exposed, the implant can develop a protein-rich pellicle that facilitates bacterial adhesion and biofilm formation. These biofilms are known to be highly resistant to both the host immune response and antimicrobial agents.

While orthopedic implants are placed in sterile body compartments, dental implants are installed directly into the oral cavity, making them uniquely vulnerable. This raises the concern: could even minimal bacterial exposure compromise implant success?

Objective of the Review

This systematic review aimed to investigate whether bacterial contamination during implant surgery impacts osseointegration or clinical outcomes. The focus was on preclinical studies that intentionally contaminated implants before insertion to simulate real-world risks.

Study Selection and Methods

A structured literature search was conducted using PubMed, Cochrane Library, Scopus, and Embase. Studies were included if they involved:

• Animal or human models,
• Bacterial contamination at the time of implant placement,
• A control group with non-contaminated implants,
• Measured outcomes such as implant survival, bone-to-implant contact (BIC), or biomechanical stability.

After screening 2,046 articles and reviewing 29 in full, five preclinical animal studies were included. However, due to high variability in study design and high risk of bias, meta-analysis was not possible.

Fig. 1. Flowchart of study selection.

Summary of Included Studies

1. Freire et al. (2011)

Rough-surfaced implants contaminated with Aggregatibacter actinomycetemcomitans were placed in rats. Six weeks later, radiological analysis showed significantly less bone volume around contaminated implants compared to controls.

Fig. 2. Bone volume differences at 6 weeks post-op.

2. Ivanoff et al. (1996)

Machined implants were exposed to soft tissue contamination in rabbits before placement. Although there was no implant loss, no significant differences in BIC or bone area within the threads were observed after 12 weeks.

3. Oosterbos et al. (2002)

Rabbits received implants contaminated with varying levels of Staphylococcus aureus. Measurements of BIC and bone area revealed inconsistent outcomes across contamination levels and implant surfaces.

4. Yuan et al. (2014)

Forty implants with different surfaces (machined, oxidized, sandblasted, hydroxyapatite-coated) were contaminated with Prevotella intermedia. Despite cleaning, residual bacteria remained. Rough-surfaced contaminated implants had significantly lower BIC and torque values compared to controls.

5. Bonsignore et al. (2013)

Over 500 mouse femur implants were contaminated with lipopolysaccharides (LPS). Implants with higher LPS exposure showed reduced BIC and lower pull-out strength, suggesting compromised mechanical stability.

Limitations of Current Evidence

All five studies were preclinical and rated as high risk of bias due to issues such as lack of blinding, inconsistent methodologies, or poor reporting. Additional concerns include:

• Different implant surfaces and designs,
• Variations in bacterial contaminants used,
• Lack of standardization in outcome measurement (e.g., ground section thickness),
• Short follow-up periods (mostly under 12 weeks).

Clinical Takeaways

While the quality of current evidence is low, some findings suggest that bacterial contamination, particularly on rough surfaces, could impair osseointegration. This effect appears more pronounced when bacterial biofilms are already established before placement.

Interestingly, no study found an increased rate of early implant loss due to contamination, but reduced BIC and torque strength may indicate long-term vulnerability.

Until more robust data is available, the safest clinical approach is to minimize contamination risk during surgery:

• Maintain strict sterile protocols,
• Minimize salivary contact with implants,
• Consider surface properties when choosing implants for high-risk patients.

Conclusion

Current evidence is insufficient to draw firm conclusions about the clinical impact of bacterial contamination during implant surgery. However, preliminary data suggests it may hinder bone integration, particularly on rough implant surfaces.

Further well-designed studies are needed. For now, clinicians should exercise heightened attention to sterility and contamination control during implant procedures to promote optimal osseointegration and long-term success.

The original article published by: Krister Johansson, DDS,* Ryo Jimbo, DDS, PhD,† Pernilla Östlund, PhD,‡ Sofia Tranæus, DDS, PhD, and Jonas P. Becktor, DDS, PhD